Can this Q3 update get the Smith & Nephew share price moving again?

After a few tough years blighted by the pandemic, the outlook might be getting a bit brighter for the Smith & Nephew share price.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Smith & Nephew (LSE: SN.) share price has fallen 40% over five years. But it’s been picking up a bit in the past few months.

And we just had a third-quarter update on Thursday (31 October). So what does the company, best known for its orthopaedics products, look like now?

Created with Highcharts 11.4.3Smith & Nephew Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

Slower growth

In the quarter, revenue rose by 4%. But the Chinese market was a bit weak, and excluding China we saw 5.9% revenue growth.

Should you invest £1,000 in Smith & Nephew Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Smith & Nephew Plc made the list?

See the 6 stocks

For the full year, the board now expects to post underlying revenue growth of 4.5%, down from previous guidance of 5%-6%. And that’s really down to China.

From 2025, Smith & Nephew expects “to expand our trading profit margin significantly to between 19.0% and 20.0%.”

We’re looking at a high-ish forecast price-to-earnings (P/E) ratio of 24 for the current year. But predicted rises in earnings in the next few years could drop that to under 15 as early as 2026.

Defensive stock

Smith & Nephew has been one of the leaders in the field of orthopaedics surgery for years, as well as sports medicine and wound management.

An ageing developed world population can surely only mean greater demand for hip and knee replacements, and the like. And growing wealth in the developing world could strengthen that further.

So this should be a strong defensive stock against all kinds of economic pressures… except, it seems, a global pandemic.

That’s the kind of thing that pushes elective surgery into the background. It delays non-urgent procedures, which would otherwise take up needed medical services and also worsen the risk of pandemic contagion.

Out of it

We’re out of all that now. And it boosts my confidence in the rosy projections that the analysts have down for the company.

But there’s a key lesson here for me. No investment can ever be defensive against all eventualities, and everything carries its own risk. And even if we don’t know what that risk is, it’s often something we just haven’t thought of yet.

Diversification, that’s the answer. Even that’s not foolproof, but it can seriously lower the danger.

In the next few years, I fear that global inflation, plus rising costs of raw materials and other source components, provide the main risk.

Growing East/West trade tensions could further damage a potentially lucrative part of the company’s market centred on China too, as we’ve just seen.

I like it

Still, even with the uncertainties, I like the look of Smith & Nephew now, and it’s on my Stocks and Shares ISA candidates list.

I’m always wary of broker price targets, but I think they can at least help me get a feel for market sentiment. And at the moment, there’s an average target of 1,350p for a 23% gain.

If it comes off, it could lift the projected 2026 P/E to only around 18. Earnings forecasts might be shaved back a bit due to weaker Chinese sales and push that up. But with improving growth prospects, I think I see the kind of safety margin I like.

But there may be an even bigger investment opportunity that’s caught my eye:

Investing in AI: 3 Stocks with Huge Potential!

🤖 Are you fascinated by the potential of AI? 🤖

Imagine investing in cutting-edge technology just once, then watching as it evolves and grows, transforming industries and potentially even yielding substantial returns.

If the idea of being part of the AI revolution excites you, along with the prospect of significant potential gains on your initial investment…

Then you won't want to miss this special report inside Motley Fool Share Advisor – 'AI Front Runners: 3 Surprising Stocks Riding The AI Wave’!

And today, we're giving you exclusive access to ONE of these top AI stock picks, absolutely free!

Get your free AI stock pick

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Smith & Nephew Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

At a 52-week low but forecast to rise 73%! Is this growth share the FTSE’s top recovery play? 

This FTSE 100 growth share has taken an absolute beating over the past two years but Harvey Jones says the…

Read more »

Investing Articles

This FTSE 250 share offers a juicy 9.8% yield. Will it last?

This well-known FTSE 250 share has a percentage dividend yield approaching double digits. Should Christopher Ruane add the income share…

Read more »

Investing Articles

Is a £333,000 portfolio enough to retire and live off passive income?

A third of a million pounds can generate a serious amount of passive income, but relying on this sum alone…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing For Beginners

Why FTSE 100 investors should pay attention to ‘Liberation Day’

Jon Smith explains why the upcoming tariff announcement from across the pond could have an impact on the FTSE 100,…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Here’s why Nvidia stock fell 13% in March

The Nvidia stock price rise was looking unstoppable. Should investors now be wondering if the same might be true of…

Read more »

US Stock

It’s ISA deadline week! Here’s my 3-step game plan

Jon Smith tries to calm the hype around the last minute ISA rush to buy stocks and explains why he's…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£10,000 invested in BAE Systems shares at Christmas is now worth…

BAE Systems shares have been surging in the FTSE 100 in 2025, driven higher by the wavering US commitment to…

Read more »

Investing Articles

Up 19% in 2 weeks, can the Tesla share price rebound further?

Tesla's first-quarter delivery numbers came out today. Will they help persuade our writer to invest his money at the current…

Read more »